Stuart B. Parker

Stuart B. Parker, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Healthequity, Inc. and Kemper Corp. The record holds 23 filings, for trades running from 5 May 2021 to 25 June 2026.

Both buying and selling appear: 5 purchases worth €3.6M, against 2 sales worth €3.9M. Sales outweigh purchases by €265k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 16 share grants.

A typical purchase (the median) is worth €797k. Clusters matter here: 1 out of 5 purchases overlapped with buying by a colleague within 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 29 June 2026 with a share grant in Healthequity, Inc. The last insider purchase was made public on 12 November 2025, 340 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.